Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients.

Williams, Matthew; Ahuja, Tania; Raco, Veronica; Papadopoulos, John; Green, David; Yuriditsky, Eugene; Arnouk, Serena

Williams, Matthew; Ahuja, Tania; Raco, Veronica; Papadopoulos, John; Green, David; Yuriditsky, Eugene; Arnouk, Serena.

Afiliación

Williams M; Department of Pharmacy, NYU Langone, New York, NY, 10016, USA.
Ahuja T; Department of Pharmacy, NYU Langone, New York, NY, 10016, USA. tania.ahuja@nyulangone.org.
Raco V; Department of Pharmacy, NYU Langone, Brooklyn, NY, 11209, USA.
Papadopoulos J; Department of Pharmacy, NYU Langone, New York, NY, 10016, USA.
Green D; Division of Hematology, Department of Medicine, NYU Langone, New York, NY, USA.
Yuriditsky E; Division of Cardiology, Department of Medicine, NYU Langone, New York, NY, 10016, USA.
Arnouk S; Department of Pharmacy, NYU Langone, New York, NY, 10016, USA.

J Thromb Thrombolysis ; 54(2): 219-229, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35381944

Asunto(s)

Embolia Pulmonar; Tromboembolia Venosa; Anticoagulantes/efectos adversos; Inhibidores del Factor Xa/efectos adversos; Humanos; Embolia Pulmonar/tratamiento farmacológico; Pirazoles; Piridonas/efectos adversos; Rivaroxabán/efectos adversos; Tromboembolia Venosa/inducido químicamente; Tromboembolia Venosa/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Embolia Pulmonar / Tromboembolia Venosa Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: J Thromb Thrombolysis Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google